dyslipidemia

Arrowhead's plozasiran could reach $700M-plus in sales by 2032, meet major unmet need in dyslipidemia: GlobalData
Fierce Pharma
Tue, 04/16/24 - 10:05 pm
Arrowhead Pharmaceuticals
clinical trials
RNAi
plozasiran
dyslipidemia
Chasing Regeneron, Pfizer posts data on $250M cardiovascular bet
Fierce Biotech
Wed, 11/24/21 - 10:15 am
Pfizer
Regeneron
antisense
clinical trials
vupanorsen
dyslipidemia
Ligand-AstraZeneca Collaborate
Yahoo/Zacks.com
Tue, 05/20/14 - 09:28 am
Ligand
AstraZeneca
dyslipidemia
Omthera
Cholesterol drugs will continue to be market leader for a decade: report
Marketwatch
Wed, 08/21/13 - 09:43 am
dyslipidemia
statins
No Fat in This Drug Launch
Motley Fool
Sat, 05/11/13 - 11:16 am
Amarin
Vascepa
dyslipidemia
Study shows superiority of pitavastatin on LDL-C reduction in HIV adults with dyslipidemia
Pharmabiz
Sun, 03/10/13 - 12:08 pm
dyslipidemia
Kowa
HIV
Livalo
The Good News Is This Can Only Go on for 5 Years
Motley Fool
Sat, 12/15/12 - 01:13 pm
Amarin
Vascepa
dyslipidemia
hypertriglyceridemia
Veloxis, Athena ink deal for pill combining 2 heart disease drugs
Fierce Drug Delivery
Mon, 01/2/12 - 03:10 pm
Veloxis
Athena
dyslipidemia
AtorFen
Amarin: Positive ANCHOR Trial Data May Be Already Baked Into Its Price
Seeking Alpha
Fri, 04/15/11 - 09:46 am
ANCHOR
Amarin
GSK
dyslipidemia
AMR101
AstraZeneca, Abbott end Certriad license deal
Marketwatch
Wed, 12/22/10 - 09:52 pm
Certriad
AstraZeneca
Abbott Laboratories
dyslipidemia